Daiwa Securities Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$138M Buy
150,533
+12,875
+9% +$13.1M 0.4% 45
2025
Q4
$148M Buy
137,658
+8,691
+7% +$8.31M 0.47% 38
2025
Q3
$98.4M Sell
128,967
-4,243
-3% -$3.16M 0.33% 53
2025
Q2
$104M Sell
133,210
-14,230
-10% -$11.1M 0.38% 46
2025
Q1
$122M Buy
147,440
+10,843
+8% +$9.02M 0.51% 43
2024
Q4
$105M Buy
136,597
+1,232
+0.9% +$1.02M 0.47% 45
2024
Q3
$120M Buy
135,365
+21,975
+19% +$19.8M 0.55% 40
2024
Q2
$103M Buy
113,390
+6,276
+6% +$5.02M 0.55% 36
2024
Q1
$83.3M Buy
107,114
+13,694
+15% +$9.75M 0.47% 39
2023
Q4
$54.5M Buy
93,420
+4,865
+5% +$2.84M 0.34% 45
2023
Q3
$47.6M Buy
88,555
+1,771
+2% +$913K 0.34% 47
2023
Q2
$40.7M Buy
86,784
+1,458
+2% +$611K 0.27% 53
2023
Q1
$29.3M Buy
85,326
+13,239
+18% +$4.46M 0.2% 65
2022
Q4
$26.4M Buy
72,087
+2,751
+4% +$975K 0.2% 68
2022
Q3
$22.4M Buy
69,336
+256
+0.4% +$81.1K 0.19% 66
2022
Q2
$22.4M Buy
69,080
+1,770
+3% +$531K 0.17% 67
2022
Q1
$19.3M Sell
67,310
-2,290
-3% -$589K 0.12% 90
2021
Q4
$19.2M Buy
69,600
+7,335
+12% +$1.86M 0.11% 97
2021
Q3
$14.4M Sell
62,265
-1,626
-3% -$401K 0.09% 115
2021
Q2
$14.7M Sell
63,891
-5,095
-7% -$1.02M 0.1% 104
2021
Q1
$12.9M Sell
68,986
-23,567
-25% -$4.61M 0.1% 106
2020
Q4
$15.6M Buy
92,553
+42,582
+85% +$6.36M 0.12% 90
2020
Q3
$7.4M Buy
49,971
+1,975
+4% +$306K 0.07% 131
2020
Q2
$6.66M Hold
47,996
0.14% 86
2020
Q1
$6.66M Buy
47,996
+9,411
+24% +$1.29M 0.07% 136
2019
Q4
$5.07M Buy
38,585
+2,322
+6% +$269K 0.04% 192
2019
Q3
$4.05M Buy
36,263
+1,043
+3% +$116K 0.03% 220
2019
Q2
$3.9M Sell
35,220
-6,321
-15% -$744K 0.03% 221
2019
Q1
$5.39M Sell
41,541
-7,240
-15% -$880K 0.05% 167
2018
Q4
$5.64M Buy
48,781
+1,336
+3% +$149K 0.05% 158
2018
Q3
$5.09M Buy
47,445
+7,600
+19% +$760K 0.04% 215
2018
Q2
$3.4M Sell
39,845
-6,572
-14% -$540K 0.03% 296
2018
Q1
$3.59M Buy
46,417
+2,419
+5% +$195K 0.03% 283
2017
Q4
$3.72M Buy
43,998
+1,205
+3% +$103K 0.03% 281
2017
Q3
$3.66M Buy
42,793
+1,043
+2% +$85.5K 0.03% 249
2017
Q2
$3.44M Buy
41,750
+350
+0.8% +$28.6K 0.02% 250
2017
Q1
$3.48M Buy
41,400
+2,300
+6% +$184K 0.02% 252
2016
Q4
$2.88M Buy
39,100
+1,200
+3% +$89.4K 0.02% 228
2016
Q3
$3.04M Sell
37,900
-1,550
-4% -$124K 0.02% 235
2016
Q2
$3.11M Sell
39,450
-72,300
-65% -$5.44M 0.02% 231
2016
Q1
$8.05M Sell
111,750
-40,120
-26% -$3.04M 0.05% 124
2015
Q4
$12.8M Sell
151,870
-39,580
-21% -$3.28M 0.08% 90
2015
Q3
$16M Buy
191,450
+28,890
+18% +$2.44M 0.11% 79
2015
Q2
$13.6M Buy
162,560
+25,590
+19% +$1.95M 0.1% 90
2015
Q1
$9.95M Buy
136,970
+26,720
+24% +$1.9M 0.07% 105
2014
Q4
$7.61M Buy
110,250
+76,850
+230% +$5.19M 0.05% 114
2014
Q3
$2.17M Buy
33,400
+7,000
+27% +$443K 0.02% 212
2014
Q2
$1.64M Sell
26,400
-800
-3% -$47.7K 0.01% 241
2014
Q1
$1.6M Sell
27,200
-1,600
-6% -$89.3K 0.01% 249
2013
Q4
$1.47M Sell
28,800
-1,600
-5% -$80.1K 0.01% 230
2013
Q3
$1.53M Sell
30,400
-800
-3% -$41.9K 0.01% 234
2013
Q2
$1.53M Buy
+31,200
New +$1.7M 0.01% 239

Other funds holding LLY

Daiwa Securities Group's LLY Position: Q1 2026 in Review

Daiwa Securities Group increased its Eli Lilly (LLY) stake by 9.4% in Q1 2026, buying an estimated $13.1M and bringing the position to 150,533 shares worth $138M. The position accounts for 0.4% of the portfolio, ranked #45.

Daiwa Securities Group first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $148M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Daiwa Securities Group held 150,533 shares of Eli Lilly worth $138M as of Q1 2026.
  • Daiwa Securities Group bought 12,875 Eli Lilly shares in Q1 2026, an estimated $13.1M.
  • Eli Lilly made up 0.4% of Daiwa Securities Group's portfolio in Q1 2026, its #45 holding.
  • Daiwa Securities Group first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Daiwa Securities Group's Eli Lilly position peaked at $148M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.